<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yuan Q</submitter><funding>the Haiyan Science Foundation</funding><funding>the China Primary Health Care Foundation</funding><funding>the Wu Jie Ping Medical Foundation</funding><funding>the Intra-Hospital Project of 900TH Hospital of The Joint Logistics Support Force</funding><funding>China Health &amp; Medical Development Foundation</funding><pagination>71</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12802299</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Breast cancer heterogeneity complicates prognosis and treatment. Metabolic reprogramming, particularly lysine beta-hydroxybutyrylation (Kbhb) driven by ketone bodies, influences the tumor microenvironment. However, the impact of Kbhb on specific breast cancer subpopulations remains unclear. This study aims to identify Kbhb-affected tumor cell subsets and evaluate their prognostic potential.&lt;h4>Methods&lt;/h4>We integrated multi-omics data from TCGA, GEO, single-cell RNA sequencing, and spatial transcriptomics. After identifying breast cancer subpopulations influenced by Kbhb-associated genes, we validated the functional role of key genes via molecular experiments. A machine learning-based prognostic model was developed using 101 algorithm combinations.&lt;h4>Results&lt;/h4>We ide</pubmed_abstract><journal>Journal of translational medicine</journal><pubmed_title>Machine learning-based identification of kbhb-affected tumor cell subsets as prognostic and therapeutic targets in breast cancer.</pubmed_title><pmcid>PMC12802299</pmcid><funding_grant_id>No. 2023QN08</funding_grant_id><funding_grant_id>No. cphcf-2023-017</funding_grant_id><funding_grant_id>No. JJZD2021-02</funding_grant_id><funding_grant_id>No. chmdf2025-xrkt04-03</funding_grant_id><funding_grant_id>No. 320.6750.18215</funding_grant_id><pubmed_authors>Ni L</pubmed_authors><pubmed_authors>Yuan Q</pubmed_authors><pubmed_authors>Sha Y</pubmed_authors><pubmed_authors>Ye R</pubmed_authors><pubmed_authors>Deng L</pubmed_authors><pubmed_authors>Han J</pubmed_authors><pubmed_authors>Yu H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Machine learning-based identification of kbhb-affected tumor cell subsets as prognostic and therapeutic targets in breast cancer.</name><description>&lt;h4>Background&lt;/h4>Breast cancer heterogeneity complicates prognosis and treatment. Metabolic reprogramming, particularly lysine beta-hydroxybutyrylation (Kbhb) driven by ketone bodies, influences the tumor microenvironment. However, the impact of Kbhb on specific breast cancer subpopulations remains unclear. This study aims to identify Kbhb-affected tumor cell subsets and evaluate their prognostic potential.&lt;h4>Methods&lt;/h4>We integrated multi-omics data from TCGA, GEO, single-cell RNA sequencing, and spatial transcriptomics. After identifying breast cancer subpopulations influenced by Kbhb-associated genes, we validated the functional role of key genes via molecular experiments. A machine learning-based prognostic model was developed using 101 algorithm combinations.&lt;h4>Results&lt;/h4>We ide</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-11T04:58:16.197Z</modification><creation>2026-06-11T03:08:24.304Z</creation></dates><accession>S-EPMC12802299</accession><cross_references><pubmed>41382084</pubmed><doi>10.1186/s12967-025-07555-3</doi></cross_references></HashMap>